| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |